Literature DB >> 30058863

A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management.

R Michael Tuttle1, Ling Zhang2, Ashok Shaha3.   

Abstract

INTRODUCTION: In the past, total thyroidectomy was usually recommended as the initial therapeutic approach in all but the lowest risk differentiated thyroid cancers. Today, many patients with low risk papillary thyroid cancers may be candidates for either an observational management approach (active surveillance/deferred surgical intervention) or a minimalist surgical approach (thyroid lobectomy/isthmusectomy). AREAS COVERED: After a comprehensive review of the PubMed database and based on our clinical experience, we describe a clinical framework that integrates important factors in three major inter-related domains (pre-operative imaging/clinical findings, medical team characteristics, and patient characteristics) to classify a patient as either ideal, appropriate or inappropriate for conservative treatment options. As part of this clinical framework, we examine how the medical decision making construct (minimalist versus maximalist) of the patient and clinician can impact selection of initial therapy. EXPERT COMMENTARY: The dramatic rise in the incidence of very low risk differentiated thyroid cancer demands a re-evaluation of the appropriate use of more minimalistic treatment options. The selection of appropriate patients for less aggressive initial treatment options requires thoughtful, open discussions that can be aided by clinical decision making frameworks that recognize and value the medical decision making process of clinicians and patients.

Entities:  

Keywords:  Active surveillance; deferred intervention; low risk thyroid cancer; thyroid cancer; thyroid lobectomy; total thyroidectomy

Mesh:

Year:  2018        PMID: 30058863     DOI: 10.1080/17446651.2018.1449641

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  16 in total

1.  Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.

Authors:  R Michael Tuttle; Ali S Alzahrani
Journal:  J Clin Endocrinol Metab       Date:  2019-03-15       Impact factor: 5.958

2.  Nonsurgical Thermal Ablation of Thyroid Nodules: Not if, but Why, When, and How?

Authors:  Laszlo Hegedüs; Akira Miyauchi; R Michael Tuttle
Journal:  Thyroid       Date:  2020-09-07       Impact factor: 6.568

3.  Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.

Authors:  Allen S Ho; Michael Luu; Cynthia Zalt; Luc G T Morris; Irene Chen; Michelle Melany; Nabilah Ali; Chrysanta Patio; Yufei Chen; Jon Mallen St-Clair; Glenn D Braunstein; Wendy L Sacks; Zachary S Zumsteg
Journal:  Thyroid       Date:  2019-09-24       Impact factor: 6.568

4.  Invasion of a Recurrent Laryngeal Nerve from Small Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance.

Authors:  Samantha K Newman; Victoria Harries; Laura Wang; Marlena McGill; Ian Ganly; Jeffrey Girshman; R Michael Tuttle
Journal:  Thyroid       Date:  2021-12-03       Impact factor: 6.568

5.  Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.

Authors:  Lin Yan; Xinyang Li; Yingying Li; Jing Xiao; Mingbo Zhang; Yukun Luo
Journal:  Eur Radiol       Date:  2022-07-27       Impact factor: 7.034

Review 6.  Updates on the Management of Thyroid Cancer.

Authors:  Katherine A Araque; Sriram Gubbi; Joanna Klubo-Gwiezdzinska
Journal:  Horm Metab Res       Date:  2020-02-10       Impact factor: 2.936

7.  Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.

Authors:  Eleonora Molinaro; Maria Cristina Campopiano; Letizia Pieruzzi; Antonio Matrone; Laura Agate; Valeria Bottici; David Viola; Virginia Cappagli; Laura Valerio; Carlotta Giani; Luciana Puleo; Loredana Lorusso; Paolo Piaggi; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; R Michael Tuttle; Rossella Elisei
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

8.  Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.

Authors:  Alexandria D McDow; Benjamin R Roman; Megan C Saucke; Catherine B Jensen; Nick Zaborek; Jamia Linn Jennings; Louise Davies; Juan P Brito; Susan C Pitt
Journal:  Am J Surg       Date:  2020-11-12       Impact factor: 3.125

Review 9.  Active surveillance as a management strategy for papillary thyroid microcarcinoma.

Authors:  Huan Zhang; Xiangqian Zheng; Juntian Liu; Ming Gao; Biyun Qian
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

10.  Ultrasound-Guided Percutaneous Laser Ablation of the Thyroid Gland in a Swine Model: Comparison of Ablation Parameters and Ablation Zone Dimensions.

Authors:  Fourat Ridouani; R Michael Tuttle; Mario Ghosn; Duan Li; Richard J Wong; James A Fagin; Sebastien Monette; Stephen B Solomon; Juan C Camacho
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-12       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.